Literature DB >> 25817499

[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: genotype-phenotype correlation].

Catarina Mendes1, Inês Vaz Matos, Luís Ribeiro, Maria João Oliveira, Helena Cardoso, Teresa Borges.   

Abstract

INTRODUCTION: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is one of the most frequent inborn conditions. It is caused by distinct mutations in the CYP21A2 gene and in the majority of cases the disease's severity correlates with CYP21A2 allelic variation Our aim was to describe the mutational spectrum of CYP21A2 and evaluate genotype-phenotype correlation in a cohort of portuguese patients with 21-hydroxylase deficiency.
MATERIAL AND METHODS: Retrospective study of 22 patients with clinical diagnosis of 21-hydroxylase deficiency. Molecular analysis of CYP21A2 was performed and genotype-phenotype correlation was then established.
RESULTS: Genotyping was performed in 22 unrelated patients: 5 with classic salt-wasting (average age of diagnosis 10,2 days; minimum 1, maximum 20 days), 7 with classic simple virilizing (average age of diagnosis 3,5 years; minimum 0 days, maximum 7 years) and 10 with nonclassical form (average age of diagnosis 5,7 years; minimum 4 years, maximum 8 years). The most frequent genetic defects in the classic forms were I2 splice (24%) and I172N (24%), followed by Q318X (16%) and gene deletions (16%) and in the nonclassical form, the V281L (80%). The overall concordance between genotype and phenotype was 81,8%. Genotype accurately predicted phenotype in 83,3%, 100% and 90% of patients with classic salt-wasting, classic simple virilizing and nonclassical mutations, respectively. DISCUSSION: The frequency of genetic defects in our patients was comparable to similar studies. In most cases there was a good correlation between genotype and phenotype.
CONCLUSIONS: Molecular analysis of CYP21A2 provides useful information in terms of prediction of disease severity, genetic and prenatal counseling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25817499

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  5 in total

1.  Congenital Adrenal Hyperplasia with Non-functional Mutations in Both Alleles in a Clinically Unaffected Infant.

Authors:  Thomas Hoehn; Zoltan Lukacs; Wolfgang Huckenbeck; Toni Torresani; Oliver Blankenstein; Saysanasongkham Bounnack
Journal:  J Trop Pediatr       Date:  2015-12-31       Impact factor: 1.165

2.  Pseudohypoaldosteronism Type 1 Newborn Patient with a Novel Mutation in SCNN1B.

Authors:  Muhammed Seyhanli; Ozkan Ilhan; Evren Gumus; Meltem Bor; Meryem Karaca
Journal:  J Pediatr Intensive Care       Date:  2020-01-07

3.  A Case of Salt-Wasting Congenital Adrenal Hyperplasia with Triple Homozygous Mutation: Review of Literature.

Authors:  Maria Laura Iezzi; Gaia Varriale; Luca Zagaroli; Stefania Lasorella; Marco Greco; Giulia Iapadre; Alberto Verrotti
Journal:  J Pediatr Genet       Date:  2020-03-09

4.  CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica.

Authors:  Andrés Umaña-Calderón; María José Acuña-Navas; Danny Alvarado; Mildred Jiménez; Fred Cavallo-Aita
Journal:  Mol Genet Metab Rep       Date:  2021-02-09

5.  Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia.

Authors:  Hamza Nasir; Syed Ibaad Ali; Naeem Haque; Stefan K Grebe; Salman Kirmani
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.